Early Plasma Circulating Tumor DNA as a Potential Biomarker of Disease Recurrence in Non-metastatic Prostate Cancer

PURPOSE: In non-metastatic prostate cancer (nmPCa) setting, it is important to early identify the patients at risk of biochemical recurrence (BCR) for immediate postoperative intervention. Our study aimed to evaluate the potential clinical utility of circulating tumor DNA (ctDNA) for predicting dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Fei, Xiaochen, Du, Xinxing, Gong, Yiming, Liu, Jiazhou, Fan, Liancheng, Wang, Jiayi, Wang, Yanqing, Zhu, Yinjie, Pan, Jiahua, Dong, Baijun, Xue, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372593/
https://www.ncbi.nlm.nih.gov/pubmed/36915250
http://dx.doi.org/10.4143/crt.2022.1557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372593/
https://www.ncbi.nlm.nih.gov/pubmed/36915250
http://dx.doi.org/10.4143/crt.2022.1557

Ejemplares similares